Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poirier

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung CancerBenjamin H Lok, Eric E Gardner, Valentina E Schneeberger, et al.
Cancer Discovery|June 18, 2020
Lineage Reversion Drives WNT Independence in Intestinal CancerTeng Han, Sukanya Goswami, Yang Hu, et al.
Stem Cell Reports|April 21, 2023
Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cellsE A Rosado-Olivieri, B Razooky, J Le Pen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen PresentationCharles M Rudin, David Balli, W Victoria Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancerJoshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.
Science Signaling|February 7, 2019
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibitionArnaud Augert, Emily Eastwood, Ali H Ibrahim, et al.
NPJ Precision Oncology|August 20, 2025
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945Yueyang Wang, Yuan Hao, Michela Ranieri, et al.
Nano Letters|March 27, 2025
Charge State Tuning of Spin Defects in Hexagonal Boron NitrideJ Fraunié, T Clua-Provost, S Roux, et al.
Nature|June 25, 2016
A combinatorial strategy for treating KRAS-mutant lung cancerEusebio Manchado, Susann Weissmueller, John P Morris, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2020
TMEM41B is a pan-flavivirus host factorH-Heinrich Hoffmann, William M Schneider, Kathryn Rozen-Gagnon, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung CancerBenjamin H Lok, Eric E Gardner, Valentina E Schneeberger, et al.
Cancer Discovery|June 18, 2020
Lineage Reversion Drives WNT Independence in Intestinal CancerTeng Han, Sukanya Goswami, Yang Hu, et al.
Stem Cell Reports|April 21, 2023
Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cellsE A Rosado-Olivieri, B Razooky, J Le Pen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen PresentationCharles M Rudin, David Balli, W Victoria Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancerJoshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.
Science Signaling|February 7, 2019
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibitionArnaud Augert, Emily Eastwood, Ali H Ibrahim, et al.
NPJ Precision Oncology|August 20, 2025
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945Yueyang Wang, Yuan Hao, Michela Ranieri, et al.
Nano Letters|March 27, 2025
Charge State Tuning of Spin Defects in Hexagonal Boron NitrideJ Fraunié, T Clua-Provost, S Roux, et al.
Nature|June 25, 2016
A combinatorial strategy for treating KRAS-mutant lung cancerEusebio Manchado, Susann Weissmueller, John P Morris, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2020
TMEM41B is a pan-flavivirus host factorH-Heinrich Hoffmann, William M Schneider, Kathryn Rozen-Gagnon, et al.
Pageof 12